Next Article in Journal
Electrochemical Lithium Extraction with Gas Flushing of Porous Electrodes
Next Article in Special Issue
The Toxicological Assessment of Anoectochilus burmannicus Ethanolic-Extract-Synthesized Selenium Nanoparticles Using Cell Culture, Bacteria, and Drosophila melanogaster as Suitable Models
Previous Article in Journal
Viricidal Activity of Thermoplastic Polyurethane Materials with Silver Nanoparticles
Previous Article in Special Issue
Green Synthesized Gold and Silver Nanoparticles Increased Oxidative Stress and Induced Cell Death in Colorectal Adenocarcinoma Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 13
Issue 9
10.3390/nano13091470
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Hemolytic Activity and Cytotoxicity of Synthetic Nanoclays with Montmorillonite Structure for Medical Applications

by
Olga Yu. Golubeva
*,
Yulia A. Alikina
,
Elena Yu. Brazovskaya
and
Nadezhda M. Vasilenko
Laboratory of Silicate Sorbents Chemistry, Institute of Silicate Chemistry of Russian Academy of Sciences, Adm. Makarova emb., 2, 199034 St. Petersburg, Russia
*
Author to whom correspondence should be addressed.
Nanomaterials 2023, 13(9), 1470; https://doi.org/10.3390/nano13091470
Submission received: 9 March 2023 / Revised: 17 April 2023 / Accepted: 23 April 2023 / Published: 25 April 2023
(This article belongs to the Special Issue Advances in Toxicity of Nanoparticles in Organisms)
Browse Figures
Review Reports Versions Notes

Abstract

:
The factors influencing the appearance of toxicity in samples of synthetic montmorillonite with a systematically changing chemical composition Nax(Al, Mg)2-3Si4O10(OH)2 nH2O, which are potentially important for their use in medicine as drug carriers, targeted drug delivery systems, entero- and hemosorbents have been studied. Samples synthesized under hydrothermal conditions had the morphology of nanolayers self-organized into the nanosponge structures. The effect of the aluminum content, particle sizes, porosity, and ζ-potential of the samples on their toxicity was studied. The cytotoxic effect of the samples on eukaryotic cells Ea. hy 926 was determined using the MTT assay. The hemolytic activity of the samples in the wide concentration range in relation to human erythrocytes was also estimated. It has been established that the toxicity of aluminosilicate nanoparticles can be significantly reduced by correctly selecting their synthesis conditions and chemical composition, which opens up the opportunities for their use in medicine.

1. Introduction

At the moment, there are several promising areas of application of porous aluminosilicate nanostructures in medicine, which are at the stages of laboratory research or clinical trials. These areas include the development of sustained release drug carriers, targeted drug delivery systems, nanovaccines, entero-, hemo-, and application sorption, materials for purification of fibrinogen and lipoproteins [1,2,3,4,5,6,7,8,9,10,11,12].
The porous structure and developed inner surface of montmorillonites determines their unique set of properties, which combines high sorption capacity, high specific surface area, ion exchange capacity, a wide range of active centers on the surface, and biocompatibility [6,13,14]. These characteristics make montmorillonite (MT) very promising for its use in medicine. In addition, among all porous aluminosilicates and clay minerals, MT have the greatest adsorption ability for inorganic and organic cations, proteins, as well as drugs [15,16,17]. The unique adsorption characteristics of montmorillonite are due to the peculiarities of its structure, namely, the ease of increasing the interlayer distance due to adsorption and intercalation of various molecules within a very wide range, up to complete division into separate layers [18,19,20,21,22]. This property of MT is widely used to obtain various adsorption materials, in particular medical appointment, such as enterosorbents. The use of MT in medicine allows to solve the problems of removing allergens, toxins, viruses, inflammatory mediators from the body, as well as preventing their movements into the systematic bloodstream [23,24,25,26].
The development of devices and methods that ensure the extraction of pathogenetically significant compounds from the blood is extremely relevant. The problem of sepsis and septic shock is acute before modern medicine. In the recent past, sepsis ended in death in 80% of cases [27]. Recent studies have shown that it is possible to reduce mortality several times using modern extracorporeal detoxification methods-hardware cleansing of blood outside the body using physico-chemical methods, in particular using sorption methods [28]. In this regard, the search for effective and safe sorbents for extracorporeal detoxification is an urgent and socially significant task.
Currently, the main developments in the field of selective hemosorbents are carried out using synthetic and natural polymers. Carbon hemosorbents are widely used, however, they do not have selectivity and damage blood cells. High adsorption capacity of montmorillonites makes it possible to consider them as a potential material for medicine, in particular, for hemosorption. In this case, the study of cytotoxicity and hemolytic activity in samples is of great importance.
Hemolysis is the destruction of red blood cells in a blood sample, with the release of various biologically active substances from them and, most importantly, hemoglobin into plasma. The study of hemolysis of samples can be considered as a model study for their effect on biological membranes, since usually hemolysis correlates with other tests for cytotoxicity [29,30,31].
The toxicity of raw aluminosilicate minerals significantly limits the possibilities of their application in medicine. Thus, studies of hemolysis in vitro have shown the presence of hemolytic activity for a number of silicate minerals: attapulgite, chrysotile, sepiolite, palygorskite, kaolinite, montmorillonite, and illite [32,33,34,35]. It was shown [35] that heat treatment at 600 °C can reduce the hemolytic activity of the minerals. Several assumptions have been made about the presence of hemolytic activity (HA) in silicate minerals, in particular, a number of researchers have found correlations between HA and mineral surface charge [36], chemical compositions [37], particle sizes, and specific surface area [38].
Cytotoxicity studies have shown the presence of toxicity in raw clay minerals. In most cases, the harmful effect is associated with the presence of impurity phases. Thus, the cytotoxicity of natural kaolinite is most likely associated with the presence of quartz [39]. Raw MT studies have shown that it can cause cytotoxic effects at high concentrations after long-time exposure [40].
The reasons for the presence of toxicity are not completely clear. If we talk about the toxicity of inorganic nanoparticles in general, then the following parameters that affect toxicity are distinguished: particle size and specific surface area, particle shape, shape factor, degree of crystallinity, surface properties, and susceptibility to agglomeration.
Directed synthesis makes it possible to solve the problem of the variability of the chemical and phase composition of raw minerals, which are the main cause of toxicity. In addition, directed hydrothermal synthesis makes it possible to obtain silicates with specified characteristics-specific chemical composition, given particle sizes and morphology, and certain surface properties.
In this work, studies of the hemolytic activity and cytotoxicity of samples of synthetic porous aluminosilicates with the montmorillonite structure, which are characterized by certain porous-textural, microstructural characteristics, specified by the chemical composition and particle size, were carried out for the first time. Such particles can be considered as model objects to identify possible patterns between the physicochemical characteristics of inorganic nanoparticles and their toxicity.

2. Materials and Methods

2.1. Synthesis

Synthesis was carried out by hydrothermal treatment of dried gels of appropriate compositions in steel autoclaves with platinum crucibles. The composition of the initial gels was calculated based on the ideal formula of montmorillonite, which has the following form Nax(Al, Mg)2-3Si4O10(OH)2·nH2O. The surface charge deficit x was varied from 0 to 1.9 by changing the aluminum content in the composition of the initial gel, assuming that part of the magnesium in the octahedral layers is isomorphically substituted by aluminum. Starting gels were prepared using tetraethoxysilane TEOC ((C2H5O)4Si, special purity grade, ≥99.0%, Sigma, Stainheim, Germany), magnesium nitrate Mg(NO3)2·6H2O (reagent grade, Vecton, St.Petersburg, Russia), aluminum nitrate Al(NO3)3·9H2O (reagent grade, ≥97.0%, Vecton, St.Petersburg, Russia), HNO3 (reagent grade, 65 wt %, NevaReactiv, St.-Peterburg, Russia), ammonia NH4OH (special purity grade, NevaReactiv, St.-Peterburg, Russia), and ethanol C2H5OH (96 wt %). Hydrothermal treatment of gels was carried out at 350 °C (in some cases-at 250 °C) for 2–4 days at an autogenous pressure of 70 MPa.

2.2. Characterization

The samples were characterized by the complex of the physicochemical analysis methods. Chemical analysis was carried out for the content of silicon, magnesium, aluminum, and sodium. The samples were studied by X-ray phase analysis; the analysis of porous-textural characteristics was carried out using the methods of low-temperature nitrogen adsorption and benzene adsorption; the morphology of the samples was studied using electron microscopy methods; the surface properties were evaluated by analyzing the ζ-potential of the samples; the cation exchange capacity (CEC) was determined. In addition, studies of hemolysis by synthesized samples were carried out, as well as an assessment of their cytotoxicity against of human endothelial cells Ea. hy 926 using the MTT test [41]. Human endothelial cells Ea.hy 926 were derived from the American Type Culture Collection (ATCC, cat. CRL 2922, Manassas, VA, USA). Measurements were carried out at least three times for each test sample. The results are shown as a mean ± standard deviation. The methods used are described in more detail in Supplementary information file.

3. Results and Discussion

The results of the chemical analysis of the samples (Table 1) confirmed that samples with different aluminum content were obtained.
Studies of the samples by X-ray phase analysis confirmed the obtaining of single-phase samples with the montmorillonite structure with an average particle size of 20 ± 3 nm. X-ray patterns of the samples and their analysis are presented in the Supplementary information file (Figure S1).
According to the SEM analysis, all samples are characterized by a layered morphology typical of montmorillonites (Figure 1). Thin nanolayers self-organize into larger aggregates with the formation of secondary porous structures, such as nanosponges, which is clearly seen in Figure 1c, which shows the results of the study of the samples using the FIB-SEM method.
The results of ζ-potential determination (Figure 2) showed that all samples have a negative surface charge, which is typical for aluminosilicates. The zeta potential becomes more negative when the degree of substitution of magnesium for aluminum increases. At the same time, the dependence of the cation exchange capacity (CEC) of the samples on the composition has a different character-it increases with the increase in the content of aluminum oxide in the samples and passes through an extremum in the region of 50% substitution of magnesium for aluminum. The same trend, similar to the change in CEC of MT samples with their composition, was also found on the dependences of the degree of adsorption of thiamine on MT samples [42].
The specific surface area determined from the data of low-temperature nitrogen adsorption (Table 2) decreases with increasing aluminum content in the samples under study and varies from 100 up to 320 m2/g to 106 m2/g.
As can be seen from the obtained results of the influence of the composition of the samples on their hemolytic activity (HA), presented in Figure 3, all studied samples are toxic at a concentration of 10 mg/mL. The dependence of HA on the aluminum content in the samples is visible. As the aluminum content increases from 0 to 22–22%, there is a significant increase in HA (% hemolysis) up to 87%, which means a significant proportion of destroyed erythrocytes. It should be noted that for a sample that does not contain aluminum, Al0, HA is practically absent. Thus, a negative effect on the appearance of toxicity is revealed, which is exerted by the aluminum content in the composition of the samples. At the same time, the nature of the change in HA—an increase up to the composition of Al1.0 followed by a slight decrease, fully correlates with the dependence of the cation exchange capacity of the samples (Figure 3), and also there is a correlation between the measurement of HA and the course of changes in the volume of mesopores, determined from the data of benzene adsorption.
Figure 4 presents the results of studying the HA of the MT samples of various chemical compositions depending on the concentration of the sample. It follows from the data obtained that the HA of the samples increases with increasing sample concentration, however, the nature of growth for samples of different compositions is different. For example, samples of Al0 and Al0.2 compositions can be considered as non-toxic up to concentrations of 2.5 mg/g. If the hemolytic activity is less than 5%, the material will have no toxic effect and conform to the requirements of the hemolysis test for medical materials [43]. With a subsequent increase in the sample concentration, a sharp increase in hemolysis is observed in the Al0.2 sample, while the Al0 sample can be considered non-toxic in the entire range of the studied concentrations, since the hemolysis of erythrocytes in its presence does not exceed 5% even at a sample concentration of 10 mg/mL. The Al1.0 sample exhibits significant HA at any studied concentrations.
The results of the cytotoxicity study of MT samples of different chemical composition correlate with the results of the study of their HA and demonstrate the relationship between the toxicity of samples and their chemical composition. Therefore, as can be seen from Figure 5, the highest toxicity, accompanied by the lowest cell survival in the entire range of studied samples, is characteristic of aluminum-containing samples. An increase in the aluminum content in the composition of the samples is accompanied by an increase in cytotoxicity. The Al0 sample is characterized by the least cytotoxicity.
As shown earlier, the synthesis conditions affect the properties and morphology of MTs. Under hydrothermal conditions for 1–3 days, the samples obtained are thin nanolayers organized into a nanosponge structure. An increase in the duration of synthesis to 3–10 days or more leads to the growth of crystals along the c axis and to the formation of a package structure, while the particle size in the direction perpendicular to axis c both according to TEM data, and according to the results of calculations by the Scherrer formula shows little change. The formation of a packet structure is accompanied by a decrease in the specific surface area of the samples.
Figure 6 shows the effect of synthesis conditions on the hemolytic activity of samples of two compositions, Al0.2 and Al1.0, obtained at different synthesis times. As can be seen from the presented results, the formation of the MT packet structure and the growth of crystals along the c axis is accompanied by a significant increase in their hemolytic activity, and, consequently, toxicity. This explains the presence of significant toxicity in natural clay minerals. Directed synthesis conditions make it possible to control the growth of crystals and obtain them in the form of nanolayers rather than plates, which can significantly reduce their toxicity.
It was shown [35] that heat treatment at 600 °C can reduce the hemolytic activity of a number of minerals. The results of the present study did not reveal such a trend for synthetic MT samples. Samples of MT of different chemical composition were subjected to additional heat treatment for 2 h at 550 °C. The results of the HA study of the samples before and after treatment (Table 3) show that HA not only does not decrease after heat treatment, but in most cases tends to increase. The only exception is the sample with the highest aluminum content, for which a slight decrease in HA is observed after heat treatment.
It is known that the adsorption properties of MT and the numerical values of its active adsorption sites are very sensitive to temperature changes. At the same time, when heated, only the water content in the clay changes and no structural changes occur in the range up to 800–900 °C. Therefore, the observed increase in HA can be attributed precisely to the removal of physical and structural water, which may have led to a greater availability of active sites on the MT surface and an increase in toxicity. Indirectly, this trend is also confirmed by the previously described correlation between the growth of HA and the growth of mesopores in the structure of the samples.

4. Conclusions

Studies of the hemolytic activity and cytotoxicity of synthetic nanoclays with montmorillonite structure showed a certain level of toxicity in all samples. At the same time, the results obtained make it possible to identify the main patterns and factors influencing the appearance of toxicity in the studied samples, as well as to determine the optimal conditions for the synthesis of montmorillonite, which make it possible to obtain samples with minimal toxicity.
Thus, it was found that the content of aluminum in the composition of the samples dramatically affects the appearance of toxicity. As the aluminum content increases from 0 to 20–22 wt %, there is a significant increase in HA (% hemolysis) up to 87%, which means a significant proportion of destroyed erythrocytes. It should be noted that for a sample that does not contain aluminum, HA is practically absent. Aluminum free samples can be considered non-toxic in a wide range of concentrations (0.1–10 mg/mL) and suitable for their use in medicine. However, the conditions for sample synthesis should be taken into account. As studies have shown, an increase in the duration of sample synthesis from 1–3 days to 12 days is accompanied by the disappearance of the nanosponge structure and the appearance of a packet structure, which leads to a sharp increase in both cytotoxicity and hemolytic activity. In addition, a correlation was found between the porous-textural characteristics of the samples and the presence of toxicity in them—an increase in the volume of mesopores in the structure of the samples is accompanied by an increase in hemolytic activity. At the same time, no dependence of hemolytic activity on the zeta potential of the samples was found.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nano13091470/s1, description of the instruments and methods used, diffraction patterns of MT samples of different compositions (Figure S1. Diffraction patterns of MT samples of different compositions: (a)—Al0, (b)—Al0.2, (c)—Al05, (d)—Al1.2, (e)—Al1.8, (f)—Al1.9). References [44,45,46,47,48,49,50,51,52,53] are cited in the Supplementary Materials.

Author Contributions

Conceptualization, O.Y.G.; Methodology, O.Y.G.; Validation, O.Y.G., Y.A.A. and E.Y.B.; Formal Analysis, O.Y.G., E.Y.B. and Y.A.A.; Investigation, Y.A.A., E.Y.B., N.M.V.; Resources, O.Y.G.; Data Curation, O.Y.G., Y.A.A. and E.Y.B.; Writing—Original Draft Preparation, O.Y.G. All authors have read and agreed to the published version of the manuscript.

Funding

The research was funded by the Russian Science Foundation (project No. 22-23-00227, https://rscf.ru/project/22-23-00227/).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Data available on request due to restrictions eg privacy or ethical.

Acknowledgments

The authors are grateful to the employees of the Institute of Experimental Medicine O.V. Shamova and E.V. Vladimirova for conducting studies of the hemolytic activity and cytotoxicity of the samples.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ganapathy, D.; Shanmugam, R.; Pitchiah, S.; Murugan, P.; Chinnathambi, A.; Alharbi, S.A.; Durairaj, K.; Sundramoorthy, A.K. Potential Applications of Halloysite Nanotubes as Drug Carriers: A Review. J. Nanomater. 2022, 2022, 1068536. [Google Scholar] [CrossRef]
  2. Fizir, M.; Dramou, P.; Dahiru, N.S.; Ruya, W.; Huang, T.; He, H. Halloysite nanotubes in analytical sciences and in drug delivery: A review. Microchim. Acta 2018, 185, 389. [Google Scholar] [CrossRef]
  3. Golubeva, O.Y.; Brazovskaya, E.Y.; Shamova, O.V. Biological activity and sorption ability of synthetic montmorillonite modified by silver/lysozyme nanoparticles. Appl. Clay Sci. 2018, 163, 56–62. [Google Scholar] [CrossRef]
  4. Golubeva, O.Y.; Brazovskaya, E.Y.; Ul’yanova, N.Y.; Morozova, Y.A. Development of Approaches for Designing and Preparing Magnetic Nanocomposites Based on Zeolite Beta and Magnetite Nanoparticles under Hydrothermal Conditions. Glas. Phys. Chem. 2018, 44, 108–114. [Google Scholar] [CrossRef]
  5. Gao, X.; Miao, R.; Tao, Y.; Chen, X.; Wan, C.; Jia, R. Effect of Montmorillonite powder on intestinal mucosal barrier in children with abdominal Henoch–Schonlein purpura: A randomized controlled study. Medicine 2018, 97, e12577. [Google Scholar] [CrossRef]
  6. Park, J.-H.; Shin, H.-J.; Kim, M.H.; Kim, J.-S.; Kang, N.; Lee, J.-Y.; Kim, K.-T.; Lee, J.I.; Kim, D.-D. Application of montmorillonite in bentonite as a pharmaceutical excipient in drug delivery systems. J. Pharm. Investig. 2016, 46, 363–375. [Google Scholar] [CrossRef]
  7. Govea-Alonso, D.O.; García-Soto, M.J.; Betancourt-Mendiola, L.; Padilla-Ortega, E.; Rosales-Mendoza, S.; González-Ortega, O. Nanoclays: Promising Materials for Vaccinology. Vaccines 2022, 10, 1549. [Google Scholar] [CrossRef] [PubMed]
  8. Laurent, S.; Ng, E.-P.; Thirifays, C.; Lakiss, L.; Goupil, G.-M.; Mintova, S.; Burtea, C.; Oveisi, E.; Hébert, C.; de Vries, M.; et al. Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions. Toxicol. Res. 2013, 2, 270–279. [Google Scholar] [CrossRef]
  9. Satish, S.; Tharmavaram, M.; Rawtani, D. Halloysite nanotubes as a nature’s boon for biomedical applications. Nanobiomedicine 2019, 6, 1849543519863625. [Google Scholar] [CrossRef]
  10. Kraljević Pavelić, S.; Simović Medica, J.; Gumbarević, D.; Filošević, A.; Pržulj, N.; Pavelić, K. Critical Review on Zeolite Clinoptilolite Safety and Medical Applications in vivo. Front. Pharmacol. 2018, 9, 1350. [Google Scholar] [CrossRef]
  11. Bacakova, L.; Vandrovcova, M.; Kopova, I.; Jirka, I. Applications of zeolites in biotechnology and medicine—A review. Biomater. Sci. 2018, 6, 974–989. [Google Scholar] [CrossRef] [PubMed]
  12. Servatan, M.; Zarrintaj, P.; Mahmodi, G.; Kim, S.-J.; Ganjali, M.R.; Saeb, M.R.; Mozafari, M. Zeolites in drug delivery: Progress, challenges and opportunities. Drug Discov. Today 2020, 25, 642–656. [Google Scholar] [CrossRef] [PubMed]
  13. Hsu, S.; Wang, M.-C.; Lin, J.-J. Biocompatibility and antimicrobial evaluation of montmorillonite/chitosan nanocomposites. Appl. Clay Sci. 2012, 56, 53–62. [Google Scholar] [CrossRef]
  14. Ijagbemi, C.O.; Baek, M.-H.; Kim, D.-S. Montmorillonite surface properties and sorption characteristics for heavy metal removal from aqueous solutions. J. Hazard. Mater. 2009, 166, 538–546. [Google Scholar] [CrossRef] [PubMed]
  15. Golubeva, O.Y.; Maslennikova, T.P.; Ulyanova, N.Y.; Dyakina, M.P. Sorption of lead(II) ions and water vapors by synthetic hydro- and aluminosilicates with layered, framework, and nanotube morphology. Glas. Phys. Chem. 2014, 40, 250–255. [Google Scholar] [CrossRef]
  16. Golubeva, O.Y.; Alikina, Y.; Brazovskaya, E.; Ugolkov, V.V. Peculiarities of the 5-fluorouracil adsorption on porous aluminosilicates with different morphologies. Appl. Clay Sci. 2019, 184, 105401. [Google Scholar] [CrossRef]
  17. Golubeva, O.Y.; Alikina, Y.A.; Brazovskaya, E.Y.; Vasilenko, N.M. Adsorption Properties and Hemolytic Activity of Porous Aluminosilicates in a Simulated Body Fluid. ChemEngineering 2022, 6, 78. [Google Scholar] [CrossRef]
  18. Funes, I.G.A.; Peralta, M.E.; Pettinari, G.R.; Carlos, L.; Parolo, M.E. Facile modification of montmorillonite by intercalation and grafting: The study of the binding mechanisms of a quaternary alkylammonium surfactant. Appl. Clay Sci. 2020, 195, 105738. [Google Scholar] [CrossRef]
  19. Block, K.A.; Trusiak, A.; Katz, A.; Alimova, A.; Wei, H.; Gottlieb, P.; Steiner, J.C. Exfoliation and intercalation of montmorillonite by small peptides. Appl. Clay Sci. 2015, 107, 173–181. [Google Scholar] [CrossRef]
  20. Pannirselvam, M.; Gupta, R.K.; Bhattacharya, S.N.; Shanks, R.A. Intercalation of Montmorillonite by Interlayer Adsorption and Complex Formation. Adv. Mater. Res. 2007, 29–30, 295–298. [Google Scholar] [CrossRef]
  21. Hou, H.; Hu Huang, Y.; Gui, R.; Zhang, L.; Tao, Q.; Zhang, C.; Tian, S.; Komarneni, S.; Ping, Q. Preparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular delivery. Appl. Clay Sci. 2016, 119, 277–283. [Google Scholar] [CrossRef]
  22. Baldassari, S.; Komarneni, S.; Mariani, E.; Villa, C. Microwave versus conventional preparation of organoclays from natural and synthetic clays. Appl. Clay Sci. 2006, 31, 134–141. [Google Scholar] [CrossRef]
  23. Fatullayeva, S.; Tagiyev, D.; Zeynalov, N. A review on enterosorbents and their application in clinical practice: Removal of toxic metals. Colloid Interface Sci. Commun. 2021, 45, 100545. [Google Scholar] [CrossRef]
  24. Golubeva, O.Y.; Shamova, O.V.; Yakovlev, A.V.; Zharkova, M.S. Synthesis and study of the biologically active lysozyme–silver nanoparticles–montmorillonite K10 complexes. Glas. Phys. Chem. 2016, 42, 87–94. [Google Scholar] [CrossRef]
  25. Phillips, T.D.; Lemke, S.L.; Grant, P.G. Characterization of Clay-Based Enterosorbents for the Prevention of Aflatoxicosis BT—Mycotoxins and Food Safety; DeVries, J.W., Trucksess, M.W., Jackson, L.S., Eds.; Springer: Boston, MA, USA, 2002; pp. 157–171. [Google Scholar] [CrossRef]
  26. Lipson, S.M.; Stotzky, G. Specificity of virus adsorption to clay minerals. Can. J. Microbiol. 1985, 31, 50–53. [Google Scholar] [CrossRef] [PubMed]
  27. Permpikul, C.; Sivakorn, C.; Tongyoo, S. In-Hospital Death after Septic Shock Reversal: A Retrospective Analysis of In-Hospital Death among Septic Shock Survivors at Thailand’s Largest National Tertiary Referral Center. Am. J. Trop. Med. Hyg. 2021, 104, 395–402. [Google Scholar] [CrossRef]
  28. Mitzner, S.R.; Stange, J.; Klammt, S.; Peszynski, P.; Schmidt, R.; Nöldge-Schomburg, G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J. Am. Soc. Nephrol. 2001, 12 (Suppl. S1), S75–S82. [Google Scholar] [CrossRef]
  29. Greco, I.; Molchanova, N.; Holmedal, E.; Jenssen, H.; Hummel, B.D.; Watts, J.L.; Håkansson, J.; Hansen, P.R.; Svenson, J. Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Sci. Rep. 2020, 10, 13206. [Google Scholar] [CrossRef]
  30. Chen, Z.; Duan, H.; Tong, X.; Hsu, P.; Han, L.; Morris-Natschke, S.L.; Yang, S.; Liu, W.; Lee, K.-H. Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives. J. Nat. Prod. 2018, 81, 465–474. [Google Scholar] [CrossRef]
  31. Sæbø, I.P.; Bjørås, M.; Franzyk, H.; Helgesen, E.; Booth, J.A. Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity. Int. J. Mol. Sci. 2023, 24, 2914. [Google Scholar] [CrossRef]
  32. Perderiset, M.; Etienne, L.S.; Bignon, J.; Jaurand, M.C. Interactions of attapulgite (fibrous clay) with human red blood cells. Toxicol. Lett. 1989, 47, 303–309. [Google Scholar] [CrossRef]
  33. Secchi, G.C.; Rezzonico, A. Hemolytic activity of asbestos dusts. Med. Lav. 1968, 59, 1–5. [Google Scholar] [PubMed]
  34. Mányai, S.; Kabai, J.; Kis, J.; Süveges, E.; Timár, M. The in vitro hemolytic effect of various clay minerals. Med. Lav. 1969, 60, 331–342. [Google Scholar]
  35. Mányai, S.; Kabai, J.; Kis, J.; Süveges, É.; Timár, M. The effect of heat treatment on the structure of kaolin and its in vitro hemolytic activity. Environ. Res. 1970, 3, 187–198. [Google Scholar] [CrossRef]
  36. Light, W.G.; Wei, E.T. Surface charge and asbestos toxicity. Nature 1977, 265, 537–539. [Google Scholar] [CrossRef]
  37. Harington, J.S.; Miller, K.; Macnab, G. Hemolysis by asbestos. Environ. Res. 1971, 4, 95–117. [Google Scholar] [CrossRef] [PubMed]
  38. Oscarson, D.W.; Van Scoyoc, G.E.; Ahlrichs, J.L. Lysis of Erythrocytes by Silicate Minerals. Clays Clay Miner. 1986, 34, 74–80. [Google Scholar] [CrossRef]
  39. Carretero, M.I.; Gomes, C.S.F.; Tateo, F. Chapter 11.5 Clays and Human Health. In Handbook of Clay Science; Bergaya, F., Theng, B.K.G., Lagaly, G., Eds.; Elsevier: Amsterdam, The Netherlands, 2006; pp. 717–741. [Google Scholar] [CrossRef]
  40. Baek, M.; Lee, J.A.; Choi, S.J. Toxicological effects of a cationic clay, montmorillonite in vitro and in vivo. Mol. Cell. Toxicol. 2012, 8, 95–101. [Google Scholar] [CrossRef]
  41. Zhang, Y.; Zhang, K.; Li, Z.; Zhang, H.; Guo, T.; Li, Y.; Zhao, J.; Feng, N. DOC-LS, a new liposome for dermal delivery, and its endocytosis by HaCaT and CCC-ESF-1 cells. IET Nanobiotechnol. 2018, 12, 1037–1041. [Google Scholar] [CrossRef]
  42. Golubeva, O.Y.; Pavlova, S.V.; Yakovlev, A.V. Adsorption and in vitro release of vitamin B1 by synthetic nanoclays with montmorillonite structure. Appl. Clay Sci. 2015, 112–113, 10–16. [Google Scholar] [CrossRef]
  43. Chen, D.; Tang, Q.; Li, X.; Zhou, X.; Zang, J.; Xue, W.; Xiang, J.; Guo, C. Biocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells. Int. J. Nanomed. 2012, 7, 4973–4982. [Google Scholar] [CrossRef] [PubMed]
  44. Thomas, F.; Michot, L.J.; Vantelon, D.; Montargès, E.; Prélot, B.; Cruchaudet, M.; Delon, J.F. Layer charge and electrophoretic mobility of smectites, Colloids Surfaces A Physicochem. Eng. Asp. 1999, 159, 351–358. [Google Scholar] [CrossRef]
  45. Dubinin, M.M. Equivalent equations for micropore adsorption. Bull. Acad. Sci. USSR Div. Chem. Sci. 1978, 27, 456–461. [Google Scholar] [CrossRef]
  46. Serpinski, V.V.; Jakubov, T.S. Dubinin–Radushkevich Equation as the Equation for the Excess Adsorption Isotherm. Adsorpt. Sci. Technol. 1993, 10, 85–92. [Google Scholar] [CrossRef]
  47. Bering, B.P.; Dubinin, M.M.; Serpinsky, V.V. Theory of volume filling for vapor adsorption. J. Colloid Interface Sci. 1966, 21, 378–393. [Google Scholar] [CrossRef]
  48. Shafer, W. Antibacterial Peptide Protocols (Methods in Molecular Biology); Humana: Totowa, NJ, USA, 1997; 269p. [Google Scholar]
  49. Kopeikin, P.M.; Zharkova, M.S.; Kolobov, A.A.; Smirnova, M.P.; Sukhareva, M.S.; Umnyakova, E.S.; Kokryakov, V.N.; Orlov, D.S.; Milman, B.L.; Balandin, S.V.; et al. Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs. Front. Cell. Infect. Microbiol. 2020, 10, 552905. [Google Scholar] [CrossRef] [PubMed]
  50. Golubeva, O.Y.; Alikina, Y.A.; Khamova, T.V.; Vladimirova, E.V.; Shamova, O.V. Aluminosilicate Nanosponges: Synthesis, Properties, and Application Prospects. Inorg. Chem. 2021, 60, 17008–17018. [Google Scholar] [CrossRef]
  51. Golubeva, O.Y.; Alikina, Y.A.; Kalashnikova, T.A. Influence of hydrothermal synthesis conditions on the morphology and sorption properties of porous aluminosilicates with kaolinite and halloysite structures. Appl. Clay Sci. 2020, 199, 105879. [Google Scholar] [CrossRef]
  52. Tolosa, L.; Donato, M.T.; Gómez-Lechón, M.J. General Cytotoxicity Assessment by Means of the MTT Assay. Methods Mol. Biol. 2015, 1250, 333–348. [Google Scholar] [CrossRef]
  53. Ghasemi, M.; Turnbull, T.; Sebastian, S.; Kempson, I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int. J. Mol. Sci. 2021, 22, 12827. [Google Scholar] [CrossRef]
Nanomaterials 13 01470 g001 550
Figure 1. The results of the study of samples by scanning electron microscopy: (a)—Al0, (b)—Al0.2, (c)—Al1.0, (d)—Al1.8 (FIB-SEM image).
Figure 1. The results of the study of samples by scanning electron microscopy: (a)—Al0, (b)—Al0.2, (c)—Al1.0, (d)—Al1.8 (FIB-SEM image).
Nanomaterials 13 01470 g001
Nanomaterials 13 01470 g002 550
Figure 2. Dependence of the cation exchange capacity (■) and zeta potential (▲) of MT samples on the degree of substitution of magnesium for aluminum in octahedral layers.
Figure 2. Dependence of the cation exchange capacity (■) and zeta potential (▲) of MT samples on the degree of substitution of magnesium for aluminum in octahedral layers.
Nanomaterials 13 01470 g002
Nanomaterials 13 01470 g003 550
Figure 3. Dependence of hemolytic activity and mesopore volume in MT samples on the degree of substitution of magnesium for aluminum in them.
Figure 3. Dependence of hemolytic activity and mesopore volume in MT samples on the degree of substitution of magnesium for aluminum in them.
Nanomaterials 13 01470 g003
Nanomaterials 13 01470 g004 550
Figure 4. Hemolytic activity of the samples. Sample designations are given in accordance with Table 1.
Figure 4. Hemolytic activity of the samples. Sample designations are given in accordance with Table 1.
Nanomaterials 13 01470 g004
Nanomaterials 13 01470 g005 550
Figure 5. Dependence of cell survival on samples concentration.
Figure 5. Dependence of cell survival on samples concentration.
Nanomaterials 13 01470 g005
Nanomaterials 13 01470 g006 550
Figure 6. Effect of sample synthesis time on their hemolytic activity: (a)—Al0.2, 2 days; (b)—Al0.2, 12 days; (c)—Al1.0, 1 day; (d)—Al1.0, 12 days.
Figure 6. Effect of sample synthesis time on their hemolytic activity: (a)—Al0.2, 2 days; (b)—Al0.2, 12 days; (c)—Al1.0, 1 day; (d)—Al1.0, 12 days.
Nanomaterials 13 01470 g006
Table
Table 1. Chemical composition and denotation of some samples studied.
Table 1. Chemical composition and denotation of some samples studied.
Sample DenotationComposition by SynthesisOxide Contents by Analysis, wt %
SiO2Al2O3MgONa2O
Al0NaxMg3Si4O10(OH)2·nH2O54.11-32.520.11
Al0.2NaxAl0.2Mg1.8Si4O10(OH)2·nH2O58.105.3218.313.52
Al0.5NaxAl0.5Mg1.5Si4O10(OH)2·nH2O56.0112.0813.733.47
Al1.0NaxAl1.0Mg1.0Si4O10(OH)2·nH2O53.8922.828.043.2
Al1.8NaxAl1.8Mg0.2Si4O10(OH)2·nH2O56.9624.812.102.99
Table
Table 2. Parameters of the porous structure of MT samples determined from the data of benzene adsorption (Ws, Vmic, Vmes) and low-temperature nitrogen adsorption (SSA).
Table 2. Parameters of the porous structure of MT samples determined from the data of benzene adsorption (Ws, Vmic, Vmes) and low-temperature nitrogen adsorption (SSA).
Samples DenotationSSA, m2/gWs, cm3/gVmic, cm3/gVmes, cm3/g
Al0.23200.5090.1710.338
Al0.52070.5690.1090.460
Al1.01900.7220.0360.686
Al1.81060.4740.0660.408
SSA—specific surface area, BET method; Ws—limiting volume of sorption space; Vmic—micropore volume; Vmes—mesopores volume.
Table
Table 3. Hemolytic activity of samples (10 mg/mL) before and after heat treatment at 500 °C.
Table 3. Hemolytic activity of samples (10 mg/mL) before and after heat treatment at 500 °C.
Sample
Denotation		% Hemolysis
before Heat Treatment		% Hemolysis after Heat Treatment
Al04.2 ± 0.319.5 ± 0.6
Al0.534.3 ± 1.054.6 ± 1.2
Al1.086.9 ± 1.269.1 ± 3.4
Al1.871.2 ± 2.154.0 ± 0.7
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Golubeva, O.Y.; Alikina, Y.A.; Brazovskaya, E.Y.; Vasilenko, N.M. Hemolytic Activity and Cytotoxicity of Synthetic Nanoclays with Montmorillonite Structure for Medical Applications. Nanomaterials 2023, 13, 1470. https://doi.org/10.3390/nano13091470

AMA Style

Golubeva OY, Alikina YA, Brazovskaya EY, Vasilenko NM. Hemolytic Activity and Cytotoxicity of Synthetic Nanoclays with Montmorillonite Structure for Medical Applications. Nanomaterials. 2023; 13(9):1470. https://doi.org/10.3390/nano13091470

Chicago/Turabian Style

Golubeva, Olga Yu., Yulia A. Alikina, Elena Yu. Brazovskaya, and Nadezhda M. Vasilenko. 2023. "Hemolytic Activity and Cytotoxicity of Synthetic Nanoclays with Montmorillonite Structure for Medical Applications" Nanomaterials 13, no. 9: 1470. https://doi.org/10.3390/nano13091470

APA Style

Golubeva, O. Y., Alikina, Y. A., Brazovskaya, E. Y., & Vasilenko, N. M. (2023). Hemolytic Activity and Cytotoxicity of Synthetic Nanoclays with Montmorillonite Structure for Medical Applications. Nanomaterials, 13(9), 1470. https://doi.org/10.3390/nano13091470

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop